STOCK TITAN
  1. Home
  2. Sec-filings
  3. SYRA
  4. [Form 4] Syra Health Corp Insider Trading Activity

Syra Health (SYRA) CEO receives 368,458 performance stock units tied to financial goals

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Syra Health Corp reported that CEO Alexander Gregory R. received a grant of 368,458 Performance Stock Units linked to Class A Common Stock. The units carry a zero exercise price and expire on August 11, 2036. According to the vesting terms, 20% of the Performance Stock Units vest one year after the grant date, with the remaining units vesting upon achievement of specified company financial metrics, tying a substantial portion of this award to the company’s future performance.

Positive

  • None.

Negative

  • None.
Insider Alexander Gregory R.
Role CEO
Type Security Shares Price Value
Grant/Award Performance Stock Units F1 368,458 $0.00 $0.00
Holdings After Transaction: Performance Stock Units — 368,458 shares (Direct)
Footnotes (1)
  1. F1. 20% of the Performance Stock Units vest one year after date of grant and the remainder vest upon the achievement of certain company financial metrics.
Performance Stock Units granted 368,458 units Grant of Performance Stock Units to CEO on August 11, 2026
Underlying Class A Common Stock 368,458 shares Shares underlying the granted Performance Stock Units
Exercise/Conversion Price $0.00 per share Exercise or conversion price for the Performance Stock Units
Initial time-based vesting portion 20% Portion of PSUs vesting one year after date of grant
Expiration date August 11, 2036 Expiration of the Performance Stock Units award
Total PSUs held after grant 368,458 units Total Performance Stock Units directly owned by CEO after this transaction
Performance Stock Units financial
"20% of the Performance Stock Units vest one year after date of grant"
Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.
vesting financial
"20% of the Performance Stock Units vest one year after date of grant"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
underlying security financial
"underlying_security_title: Class A Common Stock"

FAQ

What equity award did Syra Health (SYRA) grant to its CEO?
Syra Health granted CEO Alexander Gregory R. 368,458 Performance Stock Units tied to Class A Common Stock. These units have a $0.00 exercise price, expire on August 11, 2036, and are structured as a performance-based equity incentive.

How do the Performance Stock Units for Syra Health (SYRA) CEO vest?
20% of the Performance Stock Units vest one year after the grant date. The remaining 80% vest only upon achievement of specified company financial metrics, linking most of the award’s value to Syra Health’s future operating performance.

What is the exercise price of the Syra Health (SYRA) CEO’s Performance Stock Units?
The CEO’s 368,458 Performance Stock Units have an exercise or conversion price of $0.00 per share. This means no cash payment is required upon conversion into Class A Common Stock, subject to vesting conditions being satisfied.

When do the Syra Health (SYRA) CEO Performance Stock Units expire?
The Performance Stock Units granted to the CEO expire on August 11, 2036. Any units that have not vested or been settled into Class A Common Stock by that expiration date would no longer be exercisable under the terms described.

How many underlying Syra Health (SYRA) shares are tied to the CEO’s Performance Stock Units?
The grant covers 368,458 underlying shares of Syra Health Class A Common Stock. Each Performance Stock Unit corresponds to one underlying share, which may be issued upon vesting and settlement, subject to the award’s performance and time-based conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Alexander Gregory R.
(Last)(First)(Middle)
C/O SYRA HEALTH CORP.
1119 KEYSTONE WAY N., #201
(Street)
CARMEL INDIANA 46032
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Syra Health Corp [ SYRA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/11/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Performance Stock Units$0.008/11/2026A368,458 (1)08/11/2036Class A Common Stock368,458$0368,458D
Explanation of Responses:
1. 20% of the Performance Stock Units vest one year after date of grant and the remainder vest upon the achievement of certain company financial metrics.
/s/ Gregory Alexander08/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR